Foster JH, Voss SD, Hall DC, Minard CG, et al. Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912). Clin Cancer Res 2021;27:3543-3548.
PMID: 33568345